WSO - April 2024 - 433

MacDonald et al.
433
Ethics
The use of the data in this project is authorized under section
45 of Ontario's Personal Health Information Protection
Act (PHIPA) and does not require review by a Research
Ethics Board.
Statistical methods
RI was stratified into quartiles for baseline and crude outcomes
analyses to aide in visualizing the data. The association
between RI (treated as a continuous variable) and the
outcomes of interest were analyzed using regression models
with restricted cubic splines. The total mean RI was
used as the reference. Analyses were adjusted for age, sex
(male vs. female), CCI (low vs. high), income quintile, living
alone prior to admission (yes vs. no), preadmission living
setting (home, assisted living, or other), rural (yes vs.
no), treated on a stroke unit at any time during their acute
inpatient stay (yes vs. no), acute care LOS (days), total
rehabilitation admission FIM, and rehabilitation institution.
Post hoc analysis included calculating the RI above which
there was diminishing incremental benefit in FIM change.
The number and proportion of patients receiving that RI or
greater was calculated. Furthermore, a propensity score
(PS) weighting analysis was conducted using stabilized
average treatment effect weights to fit each outcome model,
with the exposure of RI dichotomized into above or below
this cutoff. We performed balance diagnostics of the baseline
covariates to ensure the weighted standardized differences
were <0.1. The continuous covariates were modeled
using restricted cubic splines when estimating the PS. All
analyses were carried out using SAS version 9.4.
Results
Participants
Of 15,558 individuals admitted to inpatient stroke rehabilitation
within 72 h of discharge from acute care, 12,770 met
the inclusion criteria and were analyzed. Reasons for exclusion
included age <19 or >100 years (n = 14), rehabilitation
LOS <3 days or missing/unknown (n = 1088), admitted
from LTC or admission setting missing/unknown (n = 92),
acute stroke 5 years prior to the index date (n = 492), missing
FIM information (n = 281), missing/unknown discharge
setting (n = 25), RI<1st or >99th percentile (n = 156), discharge
to acute care (n = 541), and missing RI (n = 99).
Individuals' mean age was 72.6 years (SD = 13.4), 5877
(46.0%) were female, and 11,191 (87.6%) had an ischemic
stroke. Table 1 summarizes the individuals' clinical and
socio-demographic characteristics.
RI ranged from 5 to 162 min/day with an overall
median (Quartile 1-Quartile 3 (Q1-Q3) of 72 (54-94)
min/day. There were statistically significant differences in
the characteristics of individuals in each RI quartile.
Individuals who received greater RI were male (p trend
⩽ 0.0001), younger (p trend ⩽ 0.0001), more likely to be
treated on an acute stroke unit (p trend ⩽ 0.0001), have
longer acute LOS (p trend ⩽ 0.0001), live in a rural community
(p trend ⩽ 0.0001), be admitted from home
(p trend = 0.0001), not live alone (p trend = 0.0098), and
have moderately severe strokes (admission FIM scores:
40-80; p trend ⩽ 0.0001).
Total FIM change
As shown in Table 2, the mean total FIM change increased
as RI increased (mean FIM change 21.52 (SD = 14.73) for
quartile 1, compared with 31.52 (SD = 14.99) for quartile 4;
p ⩽ 0.0001). Figure 1 demonstrates the positive association
between RI and total FIM change remained after adjusting
for baseline factors. Despite the association, there was little
incremental improvement in FIM change after reaching a
RI of 95 min/day.
Motor and cognitive FIM change
Both motor and cognitive FIM change increased with
increasing RI (mean motor FIM change 19.20 (SD = 13.31)
for quartile 1 compared with 27.29 (SD = 13.50) for quartile
4; p ⩽ 0.0001 and mean cognitive FIM change 2.32
(SD = 3.51) for quartile 1 compared with 4.22 (SD = 3.92)
for quartile 4; p ⩽ 0.0001). In the adjusted analysis, after a
RI of 95 min/day there was minimal change in motor FIM
change; however, cognitive FIM change continued to demonstrate
improvement (Figures 2 and 3).
Rehabilitation effectiveness
Rehabilitation effectiveness increased as RI increased
(mean rehabilitation effectiveness: 44.70 (SD = 26.64) for
quartile 1 compared with 56.55 (SD = 21.27) for quartile 4;
p < 0.0001). There was minimal increase in rehabilitation
effectiveness after a RI of 85 min/day (Figure 4).
90-day home time
The amount of home time in the first 90 days poststroke
increased as RI increased. However, this association was
strongest for individuals receiving 35 min of rehabilitation
or less a day; individuals receiving a RI of 35 min/day or
less had the shortest amount of time at home (Figure 5).
Discharge location
Lower RI was strongly associated with lower probability of
discharge back to preadmission setting, most significantly
when RI was ⩽35 min/day (Figure 6). A similar picture was
seen regarding discharge to LTC, in which individuals who
received higher RI (⩾95 min/day) were significantly less
likely to be discharged to LTC (Figure 7).
International Journal of Stroke, 19(4)

WSO - April 2024

Table of Contents for the Digital Edition of WSO - April 2024

Content
WSO - April 2024 - Cover1
WSO - April 2024 - Cover2
WSO - April 2024 - 373
WSO - April 2024 - Content
WSO - April 2024 - 375
WSO - April 2024 - 376
WSO - April 2024 - 377
WSO - April 2024 - 378
WSO - April 2024 - 379
WSO - April 2024 - 380
WSO - April 2024 - 381
WSO - April 2024 - 382
WSO - April 2024 - 383
WSO - April 2024 - 384
WSO - April 2024 - 385
WSO - April 2024 - 386
WSO - April 2024 - 387
WSO - April 2024 - 388
WSO - April 2024 - 389
WSO - April 2024 - 390
WSO - April 2024 - 391
WSO - April 2024 - 392
WSO - April 2024 - 393
WSO - April 2024 - 394
WSO - April 2024 - 395
WSO - April 2024 - 396
WSO - April 2024 - 397
WSO - April 2024 - 398
WSO - April 2024 - 399
WSO - April 2024 - 400
WSO - April 2024 - 401
WSO - April 2024 - 402
WSO - April 2024 - 403
WSO - April 2024 - 404
WSO - April 2024 - 405
WSO - April 2024 - 406
WSO - April 2024 - 407
WSO - April 2024 - 408
WSO - April 2024 - 409
WSO - April 2024 - 410
WSO - April 2024 - 411
WSO - April 2024 - 412
WSO - April 2024 - 413
WSO - April 2024 - 414
WSO - April 2024 - 415
WSO - April 2024 - 416
WSO - April 2024 - 417
WSO - April 2024 - 418
WSO - April 2024 - 419
WSO - April 2024 - 420
WSO - April 2024 - 421
WSO - April 2024 - 422
WSO - April 2024 - 423
WSO - April 2024 - 424
WSO - April 2024 - 425
WSO - April 2024 - 426
WSO - April 2024 - 427
WSO - April 2024 - 428
WSO - April 2024 - 429
WSO - April 2024 - 430
WSO - April 2024 - 431
WSO - April 2024 - 432
WSO - April 2024 - 433
WSO - April 2024 - 434
WSO - April 2024 - 435
WSO - April 2024 - 436
WSO - April 2024 - 437
WSO - April 2024 - 438
WSO - April 2024 - 439
WSO - April 2024 - 440
WSO - April 2024 - 441
WSO - April 2024 - 442
WSO - April 2024 - 443
WSO - April 2024 - 444
WSO - April 2024 - 445
WSO - April 2024 - 446
WSO - April 2024 - 447
WSO - April 2024 - 448
WSO - April 2024 - 449
WSO - April 2024 - 450
WSO - April 2024 - 451
WSO - April 2024 - 452
WSO - April 2024 - 453
WSO - April 2024 - 454
WSO - April 2024 - 455
WSO - April 2024 - 456
WSO - April 2024 - 457
WSO - April 2024 - 458
WSO - April 2024 - 459
WSO - April 2024 - 460
WSO - April 2024 - 461
WSO - April 2024 - 462
WSO - April 2024 - 463
WSO - April 2024 - 464
WSO - April 2024 - 465
WSO - April 2024 - 466
WSO - April 2024 - 467
WSO - April 2024 - 468
WSO - April 2024 - 469
WSO - April 2024 - 470
WSO - April 2024 - 471
WSO - April 2024 - 472
WSO - April 2024 - 473
WSO - April 2024 - 474
WSO - April 2024 - 475
WSO - April 2024 - 476
WSO - April 2024 - 477
WSO - April 2024 - 478
WSO - April 2024 - Cover3
WSO - April 2024 - Cover4
https://europe.nxtbook.com/nxteu/sageuk/wso_202404
https://europe.nxtbook.com/nxteu/sageuk/ukstrokeforum_202402_supp
https://europe.nxtbook.com/nxteu/sageuk/wso_202403
https://europe.nxtbook.com/nxteu/sageuk/wso_202402
https://europe.nxtbook.com/nxteu/sageuk/wso_202401
https://europe.nxtbook.com/nxteu/sageuk/wso_2023123_US_UKOnly
https://europe.nxtbook.com/nxteu/sageuk/wso_2023123_ROW
https://europe.nxtbook.com/nxteu/sageuk/wso_2023101
https://europe.nxtbook.com/nxteu/sageuk/wso_202308
https://europe.nxtbook.com/nxteu/sageuk/wso_202307
https://europe.nxtbook.com/nxteu/sageuk/wso_202306
https://europe.nxtbook.com/nxteu/sageuk/wso_202304
https://europe.nxtbook.com/nxteu/sageuk/wso_202303
https://europe.nxtbook.com/nxteu/sageuk/wso_202302
https://europe.nxtbook.com/nxteu/sageuk/wso_202301
https://www.nxtbookmedia.com